Strong initial sales of the Wegovy pill will set the tone for the success of the drug in 2026 and beyond, especially in light of an anticipated orforglipron approval in April
Thomas, M.K., et al
So far, these side effects are generally described as mild to moderate in severity and are often more noticeable during the dose-escalation period or when first starting the medication
We are proud to be a leading provider of peptide therapy in McLean, VA, serving the surrounding areas of Northern Virginia and Washington, D.C., including Tysons Corner, Arlington, Falls Church, Great Falls, Fairfax County, and Vienna
The Health and Human Services budget document notes that the GLP-1 coverage chaos comes after the outgoing Biden administration left the specifics of the drugs eligibility under Medicare and Medicaid up to the Trump administration